189 related articles for article (PubMed ID: 23168260)
1. JMJD2A promotes cellular transformation by blocking cellular senescence through transcriptional repression of the tumor suppressor CHD5.
Mallette FA; Richard S
Cell Rep; 2012 Nov; 2(5):1233-43. PubMed ID: 23168260
[TBL] [Abstract][Full Text] [Related]
2. The JMJD2A demethylase regulates apoptosis and proliferation in colon cancer cells.
Kim TD; Shin S; Berry WL; Oh S; Janknecht R
J Cell Biochem; 2012 Apr; 113(4):1368-76. PubMed ID: 22134899
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic features of the JMJD2A histone demethylase in breast cancer.
Berry WL; Shin S; Lightfoot SA; Janknecht R
Int J Oncol; 2012 Nov; 41(5):1701-6. PubMed ID: 22948256
[TBL] [Abstract][Full Text] [Related]
4. miR-137 Modulates a Tumor Suppressor Network-Inducing Senescence in Pancreatic Cancer Cells.
Neault M; Mallette FA; Richard S
Cell Rep; 2016 Mar; 14(8):1966-78. PubMed ID: 26904954
[TBL] [Abstract][Full Text] [Related]
5. Conserved antagonism between JMJD2A/KDM4A and HP1γ during cell cycle progression.
Black JC; Allen A; Van Rechem C; Forbes E; Longworth M; Tschöp K; Rinehart C; Quiton J; Walsh R; Smallwood A; Dyson NJ; Whetstine JR
Mol Cell; 2010 Dec; 40(5):736-48. PubMed ID: 21145482
[TBL] [Abstract][Full Text] [Related]
6. Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence.
Zou X; Ray D; Aziyu A; Christov K; Boiko AD; Gudkov AV; Kiyokawa H
Genes Dev; 2002 Nov; 16(22):2923-34. PubMed ID: 12435633
[TBL] [Abstract][Full Text] [Related]
7. JMJD2A contributes to breast cancer progression through transcriptional repression of the tumor suppressor ARHI.
Li LL; Xue AM; Li BX; Shen YW; Li YH; Luo CL; Zhang MC; Jiang JQ; Xu ZD; Xie JH; Zhao ZQ
Breast Cancer Res; 2014 May; 16(3):R56. PubMed ID: 24886710
[TBL] [Abstract][Full Text] [Related]
8. CHD5 is a tumor suppressor at human 1p36.
Bagchi A; Papazoglu C; Wu Y; Capurso D; Brodt M; Francis D; Bredel M; Vogel H; Mills AA
Cell; 2007 Feb; 128(3):459-75. PubMed ID: 17289567
[TBL] [Abstract][Full Text] [Related]
9. Ha-Ras(G12V) induces senescence in primary and immortalized human esophageal keratinocytes with p53 dysfunction.
Takaoka M; Harada H; Deramaudt TB; Oyama K; Andl CD; Johnstone CN; Rhoades B; Enders GH; Opitz OG; Nakagawa H
Oncogene; 2004 Sep; 23(40):6760-8. PubMed ID: 15273725
[TBL] [Abstract][Full Text] [Related]
10. Histone demethylase JMJD2A drives prostate tumorigenesis through transcription factor ETV1.
Kim TD; Jin F; Shin S; Oh S; Lightfoot SA; Grande JP; Johnson AJ; van Deursen JM; Wren JD; Janknecht R
J Clin Invest; 2016 Feb; 126(2):706-20. PubMed ID: 26731476
[TBL] [Abstract][Full Text] [Related]
11. Induction of cellular senescence by oncogenic RAS.
Gupta R; Wajapeyee N
Methods Mol Biol; 2013; 1048():127-33. PubMed ID: 23929102
[TBL] [Abstract][Full Text] [Related]
12. Functional identification of LRF as an oncogene that bypasses RASV12-induced senescence via upregulation of CYCLIN E.
Vredeveld LC; Rowland BD; Douma S; Bernards R; Peeper DS
Carcinogenesis; 2010 Feb; 31(2):201-7. PubMed ID: 19942610
[TBL] [Abstract][Full Text] [Related]
13. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.
Sarkisian CJ; Keister BA; Stairs DB; Boxer RB; Moody SE; Chodosh LA
Nat Cell Biol; 2007 May; 9(5):493-505. PubMed ID: 17450133
[TBL] [Abstract][Full Text] [Related]
14. Deregulation of the histone demethylase JMJD2A is involved in human carcinogenesis through regulation of the G(1)/S transition.
Kogure M; Takawa M; Cho HS; Toyokawa G; Hayashi K; Tsunoda T; Kobayashi T; Daigo Y; Sugiyama M; Atomi Y; Nakamura Y; Hamamoto R
Cancer Lett; 2013 Aug; 336(1):76-84. PubMed ID: 23603248
[TBL] [Abstract][Full Text] [Related]
15. Depletion of CSN5 inhibits Ras-mediated tumorigenesis by inducing premature senescence in p53-null cells.
Tsujimoto I; Yoshida A; Yoneda-Kato N; Kato JY
FEBS Lett; 2012 Dec; 586(24):4326-31. PubMed ID: 23127558
[TBL] [Abstract][Full Text] [Related]
16. CHD5, a tumor suppressor that is epigenetically silenced in lung cancer.
Zhao R; Yan Q; Lv J; Huang H; Zheng W; Zhang B; Ma W
Lung Cancer; 2012 Jun; 76(3):324-31. PubMed ID: 22186629
[TBL] [Abstract][Full Text] [Related]
17. Histone demethylase JMJD2B is required for tumor cell proliferation and survival and is overexpressed in gastric cancer.
Li W; Zhao L; Zang W; Liu Z; Chen L; Liu T; Xu D; Jia J
Biochem Biophys Res Commun; 2011 Dec; 416(3-4):372-8. PubMed ID: 22133676
[TBL] [Abstract][Full Text] [Related]
18. The ability of E1A to rescue ras-induced premature senescence and confer transformation relies on inactivation of both p300/CBP and Rb family proteins.
Deng Q; Li Y; Tedesco D; Liao R; Fuhrmann G; Sun P
Cancer Res; 2005 Sep; 65(18):8298-307. PubMed ID: 16166306
[TBL] [Abstract][Full Text] [Related]
19. SCF(Fbxo22)-KDM4A targets methylated p53 for degradation and regulates senescence.
Johmura Y; Sun J; Kitagawa K; Nakanishi K; Kuno T; Naiki-Ito A; Sawada Y; Miyamoto T; Okabe A; Aburatani H; Li S; Miyoshi I; Takahashi S; Kitagawa M; Nakanishi M
Nat Commun; 2016 Feb; 7():10574. PubMed ID: 26868148
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the p53 response to oncogene-induced senescence.
Ruiz L; Traskine M; Ferrer I; Castro E; Leal JF; Kaufman M; Carnero A
PLoS One; 2008 Sep; 3(9):e3230. PubMed ID: 18800172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
